Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticoagulant Efficacy and Safety of BivalirUdin Versus heparIn During coiL Embolization in Patients With ruptureD Intracranial Aneurysms: an Open-label, Multicenter, Randomized Pilot Study（BUILD）

NCT04532333 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT04532333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04532333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticoagulant Efficacy and Safety of BivalirUdin Versus heparIn During coiL Embolization in Patients With ruptureD Intracranial Aneurysms: an Open-label, Multicenter, Randomized Pilot Study（BUILD）
Lead sponsor
Changhai Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2020
Completion date
June 30, 2021
Enrollment
236 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

subarachnoid hemorrhage, aneurysmal